Try Premium free, then continue your subscription for $5.99/month plus taxes. It’s easy to get started - just download CBC Gem, sign up for a CBC account and start your free trial. Cancel anytime. What’s New Sep 23, 2024 Version 11.21.0 ...
'description': 'March 24, 2023 | President Biden’s Ottawa visit ends with big pledges from both countries. Plus, Gwyneth Paltrow testifies in her ski collision trial.', 'live_status': 'is_live', 'thumbnail': r're:https://images.gem.cbc.ca/v1/cbc-gem/live/.*', 'timestamp': 1679...
We read every piece of feedback, and take your input very seriously. Include my email address so I can be contacted Cancel Submit feedback Saved searches Use saved searches to filter your results more quickly Cancel Create saved search Sign in Sign up Reseting focus {...
GoyalL, Meric-BernstamF, HollebecqueA, et al. Updated results of the FOENIX-CCA2 trial: efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements[J]. J Clin Oncol, 2022, 40(16_suppl): 40...
8501 -Nivolumab + chemotherapy versus chemotherapy as neoadjuvant treatment for resectable stage IIIA NSCLC: Primary endpoint results of pathological complete response (pCR) from phase II NADIM II trial. 报告时间(北京) 2022年6月5日 23...
双灶性生殖细胞瘤被视为非转移性实体。转移性生殖细胞瘤可以通过颅脑脊髓照射治疗。5年EFS(event-free survival ,无病生存率)超过70%,NGGCT受益于化疗,其次是在有残留疾病的情况下推迟手术,以及某种形式的放疗。未来的策略将着眼于减...
LBA79- GEMSTONE-303: prespecified progression-free survival (PFS) and overall survival (OS) final analyses of a phase 3 study of sugemalimab plus chemotherapy vs placebo plus chemotherapy in treatment-naïve advanced gastric or gastroesoph...
原文链接:https://www.mdpi.com/2076-2607/7/10/456/htm#B66-microorganisms-07-00456 作者|Kaliyan Barathikannan 等人 翻译|gemiu 审校|617 编辑|崔心伟 THE END 投稿/转载 联系人:胡潇航 微信号:13011291868
97P Neoadjuvant durvalumab plus gemcitabine and cisplatin(D+GemCis)versus gemcis alone for localized biliary tract cancer(BTC): Results of a randomized, multicenter, open-label, phaseⅡtrial(DEBATE)[J]. Ann Oncol, 2023, 34: S216. [14] Qin S, ...